Interim data show substantial improvements in 'Good On” time compared to other oral CD/LD therapiesCREXONT delivered ...
Amneal Pharmaceuticals (AMRX) announced new positive interim results from its ongoing Phase 4 ELEVATE-PD study, presented at the Parkinson’s Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback